DOJ Probes Cephalon Over Narcolepsy Drug Marketing
The Frazier, Pa.-based drugmaker — which Teva Pharmaceutical Industries Ltd. plans to buy for $6.8 billion — has also received another DOJ subpoena as part of an investigation into the off-label use of Treanda for non-Hodgkin's lymphoma, according to pharmaceutical blog Pharmalot.
In a U.S. Securities...
Already a subscriber? Click here to login